Home/Pipeline/CAM2038

CAM2038

Chronic Pain

Phase 3ActiveN/A

Key Facts

Indication

Chronic Pain

Phase

Phase 3

Status

Active

Company

Camurus

About Camurus

Camurus is a fully integrated, commercial-stage biopharma focused on transforming chronic disease management through its proprietary FluidCrystal® long-acting injectable technology. The company has achieved commercial success with Buvidal® for opioid dependence and is advancing a diversified pipeline in pain, oncology, and endocrinology through a dual strategy of in-house development and strategic partnerships. With a validated platform, established commercial infrastructure in key markets, and a streamlined development model, Camurus is positioned to deliver significant value to patients, healthcare systems, and shareholders.

View full company profile

Therapeutic Areas

Central Nervous System Rare Diseases Endocrinology Oncology Supportive Care

Other Chronic Pain Drugs

Drug	Company	Phase	Status
SCI-160	SciSparc	Preclinical	Active
Injectrode Platform for Chronic Pain	Neuronoff	Pre-clinical	Active
Novel PNS System	Nervonik	First-in-Human Completed	Active
Pain Pipeline	Centrexion Therapeutics	Clinical Stage	Active
High-Definition Spinal Cord Stimulation	Micro-Leads	Unknown	Active
Precision Medicine for Pain	MindX Sciences	Commercial	Active
Chronic Pain Program	Current Surgical	Research	Active
N-19a	Neurocarrus	Pre-clinical	Active
Nav1.7 ASO	Quiver Bioscience	Discovery	Active
Nav1.8 ASO	Quiver Bioscience	Discovery	Active
Dual Nav1.7/1.8 ASO	Quiver Bioscience	Discovery	Active
TMS for Chronic Pain	Magstim	Commercial/Clinical Development	Active